Stockholm - Free Realtime Quote SEK

Double Bond Pharmaceutical Int. (DBP-B.ST)

0.4140

+0.0390

+(10.40%)

As of 9:32:21 AM GMT+2. Market Open.

Stock market today: Dow, S&P 500, Nasdaq futures surge on US-China deal to slash tariffs

US and China said they have agreed to slash most tariffs for 90 days while further trade talks take place.

Yahoo Finance 3 minutes ago

NQ=F

ES=F

YM=F
CATL Starts Taking Investor Orders for World’s Biggest Listing This Year

(Bloomberg) -- Contemporary Amperex Technology Co. Ltd. has started taking investor orders for a Hong Kong stock offering that is likely to be the world’s biggest listing this year. Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsIs Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?What’s Behind the Rise in Serious Injuries on New York City’s Streets?NYC Warns of 17% Drop in For

Bloomberg 53 minutes ago

JPM

600276.SS

CNICF
3 Healthcare Stocks to Keep an Eye On

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 13%. This drop was worse than the S&P 500’s 5.5% loss.

StockStory 3 hours ago

SYK

LLY
Watch These Tesla Price Levels After Stock Rallies to Highest Close Since February

Tesla shares have posted three consecutive weeks of gains and are trading at their highest levels in more than two months. These are the crucial chart levels to monitor.

Investopedia 4 hours ago

TSLA
U.S.-China Talks End: Bessent Touts 'Substantial Progress'; White House Signals Deal

Treasury Secretary Scott Bessent cited "substantial progress" after weekend China trade talks, with more details Monday.

Investor's Business Daily 8 hours ago

WMT

BABA

BABAF
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Lilly reported in December that its obesity drug had already met the main goal, leading to 47% more weight loss than those who received Wegovy. The data is the first head-to-head trial comparing the wildly popular medicines, and gives Lilly more firepower as it seeks to gain wider insurance coverage in an obesity drug market estimated to reach more than $150 billion annually by the next decade.

Reuters 9 hours ago

LLY

NVO
Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

Eli Lilly and Company (NYSE: LLY) today announced detailed results from SURMOUNT-5, a Phase 3b open-label clinical trial, evaluating the safety and efficacy of Zepbound (tirzepatide), a dual GIP and GLP-1 receptor agonist, compared to Wegovy (semaglutide), a mono GLP-1 receptor agonist, in adults living with obesity, or overweight with at least one weight-related medical problem and without diabetes. At 72 weeks, Zepbound met the primary endpoint and all five key secondary endpoints, demonstrati

PR Newswire 9 hours ago

LLY
JD.com, Inc. (JD): Among Michael Burry Stocks with Huge Upside Potential

We recently published a list of 10 Michael Burry Stocks with Huge Upside Potential. In this article, we are going to take a look at where JD.com, Inc. (NASDAQ:JD) stands against other Michael Burry stocks with huge upside potential. Michael Burry, founder and manager of Scion Asset Management, is best known for predicting and profiting from […]

Insider Monkey 10 hours ago

JD
Alibaba Group Holding (BABA): Among Michael Burry Stocks with Huge Upside Potential

We recently published a list of 10 Michael Burry Stocks with Huge Upside Potential. In this article, we are going to take a look at where Alibaba Group Holding Limited (NYSE:BABA) stands against other Michael Burry stocks with huge upside potential. Michael Burry, founder and manager of Scion Asset Management, is best known for predicting and […]

Insider Monkey 10 hours ago

BABA
Baidu, Inc. (BIDU): Among Michael Burry Stocks with Huge Upside Potential

We recently published a list of 10 Michael Burry Stocks with Huge Upside Potential. In this article, we are going to take a look at where Baidu, Inc. (NASDAQ:BIDU) stands against other Michael Burry stocks with huge upside potential. Michael Burry, founder and manager of Scion Asset Management, is best known for predicting and profiting from […]

Insider Monkey 10 hours ago

BIDU
Is Apple Inc. (AAPL) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against other best stocks to buy according to Jim Simons’ Renaissance Technologies. Even after his passing in 2024, billionaire investor and mathematician […]

Insider Monkey 10 hours ago

AAPL
NIO Inc. (NIO): Among the High Growth EV Stocks to Invest In

We recently compiled a list of the 10 High Growth EV Stocks to Invest In. In this article, we are going to take a look at where NIO Inc. (NYSE:NIO) stands against the other best High Growth EV stocks. Automobiles that run on electricity rather than gas are referred to as electric cars, or EVs. Electric […]

Insider Monkey 11 hours ago

NIO
Tesla, Inc. (TSLA): Among the High Growth EV Stocks to Invest In

We recently compiled a list of the 10 High Growth EV Stocks to Invest In. In this article, we are going to take a look at where Tesla, Inc. (NASDAQ:TSLA) stands against the other best High Growth EV stocks. Automobiles that run on electricity rather than gas are referred to as electric cars, or EVs. Electric […]

Insider Monkey 11 hours ago

TSLA
1 Stock to Buy, 1 Stock to Sell This Week: Alibaba, Walmart

U.S. stocks ended the week on a quiet note on Friday to cap a losing week, as investors awaited much-anticipated talks between U.S. and China officials on trade and economic issues.

Investing.com 14 hours ago

WMT

BABA

COMP
Onto Innovation (NYSE:ONTO) Reports Robust Q1 2025 Earnings with Increased Sales

Onto Innovation (NYSE:ONTO) recently announced robust first-quarter 2025 earnings, with a significant year-over-year increase in sales and net income, along with positive guidance for the second quarter. Despite these strong financials, the company's stock experienced a 26% decline over the past month. This negative price movement seems disconnected from Onto's promising performance, especially as the broader market remained flat during the same period. The juxtaposition of Onto's earnings...

Simply Wall St. 14 hours ago

ONTO
Tesla Vs. BYD: TSLA Flashes Aggressive Entry While Rival Nears Buy Point

Tesla has topped an early entry while BYD stock is near a base buy point. BYD growth is booming while TSLA investors bet on robotaxis.

Investor's Business Daily 14 hours ago

TSLA

BYDDY
Here's Why I'm Not Too Worried for Alphabet Despite Apple's Potential New AI-Powered Safari Search

Investors panicked when the possibility was floated, but take a step back and look at the bigger picture.

Motley Fool 17 hours ago

GOOG

AAPL
Rivian: Should You Buy the Stock Before Its Next Big Milestone?

Rivian reached another big milestone, turning a gross profit for the second straight quarter. The electric vehicle maker is looking to advance its higher-margin software platform. Rivian Automotive (NASDAQ: RIVN) reached a big milestone when it reported its first-quarter results, producing a gross profit for the second consecutive quarter.

Motley Fool 19 hours ago

RIVN

TSLA
With 46% ownership, JD.com, Inc. (NASDAQ:JD) boasts of strong institutional backing

Key Insights Given the large stake in the stock by institutions, JD.com's stock price might be vulnerable to their...

Simply Wall St. 19 hours ago

JD

JDCMF
President Trump Just Announced Terrible News for Eli Lilly Investors

President Donald Trump vowed to impose tariffs on pharmaceuticals within two weeks. Eli Lilly, a leader in the industry, could be harmed by the move, but it is already preparing for it. President Donald Trump's second term in office has been challenging for investors, at least so far.

Motley Fool 20 hours ago

LLY

Performance Overview

Return	DBP-B.ST	OMX Stockholm 30 Index (^OMX)
YTD	+9.81%	+0.51%
1-Year	-34.08%	-5.03%
3-Year	+6.39%	+26.47%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Double Bond Pharmaceutical Int. (DBP-B.ST)

Related News

Stock market today: Dow, S&P 500, Nasdaq futures surge on US-China deal to slash tariffs

CATL Starts Taking Investor Orders for World’s Biggest Listing This Year

3 Healthcare Stocks to Keep an Eye On

Watch These Tesla Price Levels After Stock Rallies to Highest Close Since February

U.S.-China Talks End: Bessent Touts 'Substantial Progress'; White House Signals Deal

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

JD.com, Inc. (JD): Among Michael Burry Stocks with Huge Upside Potential

Alibaba Group Holding (BABA): Among Michael Burry Stocks with Huge Upside Potential

Baidu, Inc. (BIDU): Among Michael Burry Stocks with Huge Upside Potential

Is Apple Inc. (AAPL) the Best Stock to Buy According to Jim Simons’ Renaissance Technologies?

NIO Inc. (NIO): Among the High Growth EV Stocks to Invest In

Tesla, Inc. (TSLA): Among the High Growth EV Stocks to Invest In

1 Stock to Buy, 1 Stock to Sell This Week: Alibaba, Walmart

Onto Innovation (NYSE:ONTO) Reports Robust Q1 2025 Earnings with Increased Sales

Tesla Vs. BYD: TSLA Flashes Aggressive Entry While Rival Nears Buy Point

Here's Why I'm Not Too Worried for Alphabet Despite Apple's Potential New AI-Powered Safari Search

Rivian: Should You Buy the Stock Before Its Next Big Milestone?

With 46% ownership, JD.com, Inc. (NASDAQ:JD) boasts of strong institutional backing

President Trump Just Announced Terrible News for Eli Lilly Investors

Performance Overview